Endoscopy 2015; 47(05): 398-408
DOI: 10.1055/s-0034-1391285
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial

Authors

  • Shun He*

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Jacques Bergman*

    2   Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
  • Yueming Zhang*

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Bas Weusten

    2   Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, The Netherlands
    3   Department of Gastroenterology, St. Antonius Hospital, Nieuwegein, The Netherlands
  • Liyan Xue

    4   Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Xiumin Qin

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Lizhou Dou

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Yong Liu

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • David Fleischer

    5   Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, United States
  • Ning Lu

    4   Department of Pathology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
  • Sanford M. Dawsey

    6   Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States
  • Gui-Qi Wang

    1   Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China
Weitere Informationen

Publikationsverlauf

submitted 17. Februar 2014

accepted after revision 11. November 2014

Publikationsdatum:
10. Februar 2015 (online)

Preview

Background and study aims: Endoscopic radiofrequency ablation (RFA) is an established therapy for Barrett’s esophagus. Preliminary reports, limited by low patient numbers, also suggest a possible role for RFA in early esophageal squamous cell neoplasia (ESCN). The aim of this study was to evaluate the safety and effectiveness of RFA for early ESCN (moderate/high grade intraepithelial neoplasia [MGIN/HGIN] and early flat-type esophageal squamous cell carcinoma [ESCC]).

Patients and methods: This prospective cohort study included patients with at least one flat (type 0-IIb) unstained lesion (USL) on Lugol’s chromoendoscopy and a consensus diagnosis of MGIN, HGIN, or early ESCC. RFA was used at baseline to treat all USLs, and then biopsy (and focal RFA if USL persisted) was performed every 3 months until all biopsies were negative for MGIN, HGIN, and ESCC. The main outcome measurements were complete response at 3 and 12 months (absence of MGIN, HGIN, and ESCC), neoplastic progression, and adverse events.

Results: A total of 96 patients participated (MGIN 45, HGIN 42, early ESCC 9). At 3 and 12 months, 73 % (70/96) and 84 % (81/96), respectively, showed a complete response. Two patients (2 %) progressed (MGIN to HGIN; HGIN to T1m2 ESCC); both were treated endoscopically and achieved complete response. Stricture occurred in 20 patients (21 %), all after circumferential RFA. Lugol’s + RFA 12 J/cm2 (single application, no cleaning) was the favored baseline circumferential RFA technique (82 % 12-month complete response [14/17], 6 % stricture [6/17]).

Conclusion: In patients with early ESCN, RFA was associated with a high complete response rate and an acceptable safety profile.

* These authors contributed equally to this work.